This report provides a comprehensive analysis of the global Digital Chronic Disease Management market, projecting steady growth through 2032. It examines how technologies like IoT, AI, and big data enable remote monitoring and personalized interventions for conditions such as diabetes and hypertension. The study details market dynamics across various segments, including technology types and disease applications, while highlighting regional trends from North American leadership to rapid expansion in the Asia-Pacific. Furthermore, it evaluates competitive landscapes, key players, and strategic opportunities within the evolving digital healthcare ecosystem.

Market Overview

The global Digital Chronic Disease Management market is projected to grow from US$ 1135 million in 2025 to US$ 1803 million in 2032, exhibiting a compound annual growth rate (CAGR) of 6.9% from 2026 to 2032.

Definition and Core Concept

Digital Chronic Disease Management refers to a comprehensive, personalized, and remote health intervention and service system designed for chronic diseases, such as hypertension and diabetes. This system leverages several advanced technologies, including:

• Internet of Things (IoT)
• Big Data
• Artificial Intelligence (AI)
• Mobile Internet technologies

Core Functionality:

• Data Collection: Real-time collection of vital sign data through smart wearable devices.
• Analysis: Utilization of cloud platforms for data analysis and evaluation.
• Patient Support: Provision of precise medication reminders, dietary and exercise guidance, and complication warnings.

Objectives: This model aims to break down traditional spatial and temporal limitations of medical care by extending services from in-hospital treatment to continuous out-of-hospital management. The primary goals are to improve patients' self-management capabilities, optimize the allocation of medical resources, and reduce the overall social medical burden.

Regional Market Analysis

The global landscape is highly diversified across different geographical regions:

• North America: Leads in technology and dominates the remote monitoring and behavioral intervention market, supported by a mature digital healthcare ecosystem and Value-Based Care payment reforms.
• Europe: Focuses on integrating digital chronic disease management with public health systems under its universal health insurance system, with a strong emphasis on data security and clinical efficacy validation.
• Asia-Pacific: Recognized as the fastest-growing area:
• China: Rapidly penetrating the outpatient management of diabetes and hypertension through internet healthcare platforms such as Ping An Good Doctor and JD Health.
• India and Southeast Asia: Filling critical gaps in primary healthcare resources through the use of mobile health applications.

About the Report

Produced by LPI (LP Information), the “Digital Chronic Disease Management Industry Forecast” provides a detailed analysis of the global industry in US$ millions. The report reviews total world Digital Chronic Disease Management sales in 2025 and provides a comprehensive analysis of projected sales for the period of 2026 through 2032.

Key Features of the Insight Report:

• Comprehensive Analysis: Covers product segmentation, company formation, revenue, market share, latest developments, and M&A activity.
• Strategic Insights: Analyzes the strategies of leading global companies, focusing on their Digital Chronic Disease Management portfolios, capabilities, market entry strategies, market positions, and geographic footprints.
• Market Dynamics: Evaluates key market trends, drivers, and affecting factors to highlight emerging pockets of opportunity.
• Methodology: Utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a nuanced view of the market's current state and future trajectory.

Market Segmentation

By Type

• Remote Monitoring and Intervention Model
• Internet Hospital and Online Consultation Model
• Chronic Disease Management Application Model
• Others

By Technology

• IoT-Driven
• Big Data Analytics and Risk Warning
• AI-Assisted Decision Making
• Others

By Disease

• Metabolic Disease Management
• Cardiovascular and Cerebrovascular Disease Management
• Respiratory Chronic Disease Management
• Mental and Psychological Chronic Disease Management
• Cancer Rehabilitation Management
• Others

By Application

• Medical Institutions
• Pharmacy
• Chronic Disease Patients

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

The following companies have been profiled based on primary expert input and analysis of their market coverage, product portfolio, and market penetration:

• S3 Connected Health
• WellDoc
• NTT DATA
• Dawn Health
• Medtronic
• Teladoc Health
• ScienceSoft
• Cognizant
• Omada Health
• Pack Health
• Epic Systems
• EveryDose
• Aptar Digital Health
• ClouDr Group
• JD Health
• Ali Health
• Ping An Good Doctor
• We Doctor Group
• Medlinker

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Digital Chronic Disease Management Market Size (2021-2032)

    • 2.1.2 Digital Chronic Disease Management Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Digital Chronic Disease Management by Country/Region (2021, 2025 & 2032)

  • 2.2 Digital Chronic Disease Management Segment by Type

    • 2.2.1 Remote Monitoring and Intervention Model

    • 2.2.2 Internet Hospital and Online Consultation Model

    • 2.2.3 Chronic Disease Management Application Model

    • 2.2.4 Others

    • 2.2.5 Digital Chronic Disease Management Market Size by Type

      • 2.2.5.1 Digital Chronic Disease Management Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.5.2 Global Digital Chronic Disease Management Market Size Market Share by Type (2021-2026)

  • 2.3 Digital Chronic Disease Management Segment by Technology

    • 2.3.1 IoT-Driven

    • 2.3.2 Big Data Analytics and Risk Warning

    • 2.3.3 AI-Assisted Decision Making

    • 2.3.4 Others

    • 2.3.5 Digital Chronic Disease Management Market Size by Technology

      • 2.3.5.1 Digital Chronic Disease Management Market Size CAGR by Technology (2021 VS 2025 VS 2032)
      • 2.3.5.2 Global Digital Chronic Disease Management Market Size Market Share by Technology (2021-2026)

  • 2.4 Digital Chronic Disease Management Segment by Disease

    • 2.4.1 Metabolic Disease Management

    • 2.4.2 Cardiovascular and Cerebrovascular Disease Management

    • 2.4.3 Respiratory Chronic Disease Management

    • 2.4.4 Mental and Psychological Chronic Disease Management

    • 2.4.5 Cancer Rehabilitation Management

    • 2.4.6 Others

    • 2.4.7 Digital Chronic Disease Management Market Size by Disease

      • 2.4.7.1 Digital Chronic Disease Management Market Size CAGR by Disease (2021 VS 2025 VS 2032)
      • 2.4.7.2 Global Digital Chronic Disease Management Market Size Market Share by Disease (2021-2026)

  • 2.5 Digital Chronic Disease Management Segment by Application

    • 2.5.1 Medical Institutions

    • 2.5.2 Pharmacy

    • 2.5.3 Chronic Disease Patients

    • 2.5.4 Digital Chronic Disease Management Market Size by Application

      • 2.5.4.1 Digital Chronic Disease Management Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.5.4.2 Global Digital Chronic Disease Management Market Size Market Share by Application (2021-2026)

• 3 Digital Chronic Disease Management Market Size by Player

  • 3.1 Digital Chronic Disease Management Market Size Market Share by Player

    • 3.1.1 Global Digital Chronic Disease Management Revenue by Player (2021-2026)

    • 3.1.2 Global Digital Chronic Disease Management Revenue Market Share by Player (2021-2026)

  • 3.2 Global Digital Chronic Disease Management Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Digital Chronic Disease Management by Region

  • 4.1 Digital Chronic Disease Management Market Size by Region (2021-2026)

  • 4.2 Global Digital Chronic Disease Management Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Digital Chronic Disease Management Market Size Growth (2021-2026)

  • 4.4 APAC Digital Chronic Disease Management Market Size Growth (2021-2026)

  • 4.5 Europe Digital Chronic Disease Management Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Digital Chronic Disease Management Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Digital Chronic Disease Management Market Size by Country (2021-2026)

  • 5.2 Americas Digital Chronic Disease Management Market Size by Type (2021-2026)

  • 5.3 Americas Digital Chronic Disease Management Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Digital Chronic Disease Management Market Size by Region (2021-2026)

  • 6.2 APAC Digital Chronic Disease Management Market Size by Type (2021-2026)

  • 6.3 APAC Digital Chronic Disease Management Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Digital Chronic Disease Management Market Size by Country (2021-2026)

  • 7.2 Europe Digital Chronic Disease Management Market Size by Type (2021-2026)

  • 7.3 Europe Digital Chronic Disease Management Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Digital Chronic Disease Management by Region (2021-2026)

  • 8.2 Middle East & Africa Digital Chronic Disease Management Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Digital Chronic Disease Management Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Digital Chronic Disease Management Market Forecast

  • 10.1 Global Digital Chronic Disease Management Forecast by Region (2027-2032)

    • 10.1.1 Global Digital Chronic Disease Management Forecast by Region (2027-2032)

    • 10.1.2 Americas Digital Chronic Disease Management Forecast

    • 10.1.3 APAC Digital Chronic Disease Management Forecast

    • 10.1.4 Europe Digital Chronic Disease Management Forecast

    • 10.1.5 Middle East & Africa Digital Chronic Disease Management Forecast

  • 10.2 Americas Digital Chronic Disease Management Forecast by Country (2027-2032)

    • 10.2.1 United States Market Digital Chronic Disease Management Forecast

    • 10.2.2 Canada Market Digital Chronic Disease Management Forecast

    • 10.2.3 Mexico Market Digital Chronic Disease Management Forecast

    • 10.2.4 Brazil Market Digital Chronic Disease Management Forecast

  • 10.3 APAC Digital Chronic Disease Management Forecast by Region (2027-2032)

    • 10.3.1 China Digital Chronic Disease Management Market Forecast

    • 10.3.2 Japan Market Digital Chronic Disease Management Forecast

    • 10.3.3 Korea Market Digital Chronic Disease Management Forecast

    • 10.3.4 Southeast Asia Market Digital Chronic Disease Management Forecast

    • 10.3.5 India Market Digital Chronic Disease Management Forecast

    • 10.3.6 Australia Market Digital Chronic Disease Management Forecast

  • 10.4 Europe Digital Chronic Disease Management Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Digital Chronic Disease Management Forecast

    • 10.4.2 France Market Digital Chronic Disease Management Forecast

    • 10.4.3 UK Market Digital Chronic Disease Management Forecast

    • 10.4.4 Italy Market Digital Chronic Disease Management Forecast

    • 10.4.5 Russia Market Digital Chronic Disease Management Forecast

  • 10.5 Middle East & Africa Digital Chronic Disease Management Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Digital Chronic Disease Management Forecast

    • 10.5.2 South Africa Market Digital Chronic Disease Management Forecast

    • 10.5.3 Israel Market Digital Chronic Disease Management Forecast

    • 10.5.4 Turkey Market Digital Chronic Disease Management Forecast

  • 10.6 Global Digital Chronic Disease Management Forecast by Type (2027-2032)

  • 10.7 Global Digital Chronic Disease Management Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Digital Chronic Disease Management Forecast

• 11 Key Players Analysis

  • 11.1 S3 Connected Health

    • 11.1.1 S3 Connected Health Company Information

    • 11.1.2 S3 Connected Health Digital Chronic Disease Management Product Offered

    • 11.1.3 S3 Connected Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 S3 Connected Health Main Business Overview

    • 11.1.5 S3 Connected Health Latest Developments

  • 11.2 WellDoc

    • 11.2.1 WellDoc Company Information

    • 11.2.2 WellDoc Digital Chronic Disease Management Product Offered

    • 11.2.3 WellDoc Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 WellDoc Main Business Overview

    • 11.2.5 WellDoc Latest Developments

  • 11.3 NTT DATA

    • 11.3.1 NTT DATA Company Information

    • 11.3.2 NTT DATA Digital Chronic Disease Management Product Offered

    • 11.3.3 NTT DATA Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 NTT DATA Main Business Overview

    • 11.3.5 NTT DATA Latest Developments

  • 11.4 Dawn Health

    • 11.4.1 Dawn Health Company Information

    • 11.4.2 Dawn Health Digital Chronic Disease Management Product Offered

    • 11.4.3 Dawn Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Dawn Health Main Business Overview

    • 11.4.5 Dawn Health Latest Developments

  • 11.5 Medtronic

    • 11.5.1 Medtronic Company Information

    • 11.5.2 Medtronic Digital Chronic Disease Management Product Offered

    • 11.5.3 Medtronic Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Medtronic Main Business Overview

    • 11.5.5 Medtronic Latest Developments

  • 11.6 Teladoc Health

    • 11.6.1 Teladoc Health Company Information

    • 11.6.2 Teladoc Health Digital Chronic Disease Management Product Offered

    • 11.6.3 Teladoc Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Teladoc Health Main Business Overview

    • 11.6.5 Teladoc Health Latest Developments

  • 11.7 ScienceSoft

    • 11.7.1 ScienceSoft Company Information

    • 11.7.2 ScienceSoft Digital Chronic Disease Management Product Offered

    • 11.7.3 ScienceSoft Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 ScienceSoft Main Business Overview

    • 11.7.5 ScienceSoft Latest Developments

  • 11.8 Cognizant

    • 11.8.1 Cognizant Company Information

    • 11.8.2 Cognizant Digital Chronic Disease Management Product Offered

    • 11.8.3 Cognizant Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Cognizant Main Business Overview

    • 11.8.5 Cognizant Latest Developments

  • 11.9 Omada Health

    • 11.9.1 Omada Health Company Information

    • 11.9.2 Omada Health Digital Chronic Disease Management Product Offered

    • 11.9.3 Omada Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Omada Health Main Business Overview

    • 11.9.5 Omada Health Latest Developments

  • 11.10 Pack Health

    • 11.10.1 Pack Health Company Information

    • 11.10.2 Pack Health Digital Chronic Disease Management Product Offered

    • 11.10.3 Pack Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Pack Health Main Business Overview

    • 11.10.5 Pack Health Latest Developments

  • 11.11 Epic Systems

    • 11.11.1 Epic Systems Company Information

    • 11.11.2 Epic Systems Digital Chronic Disease Management Product Offered

    • 11.11.3 Epic Systems Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 Epic Systems Main Business Overview

    • 11.11.5 Epic Systems Latest Developments

  • 11.12 EveryDose

    • 11.12.1 EveryDose Company Information

    • 11.12.2 EveryDose Digital Chronic Disease Management Product Offered

    • 11.12.3 EveryDose Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 EveryDose Main Business Overview

    • 11.12.5 EveryDose Latest Developments

  • 11.13 Aptar Digital Health

    • 11.13.1 Aptar Digital Health Company Information

    • 11.13.2 Aptar Digital Health Digital Chronic Disease Management Product Offered

    • 11.13.3 Aptar Digital Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Aptar Digital Health Main Business Overview

    • 11.13.5 Aptar Digital Health Latest Developments

  • 11.14 ClouDr Group

    • 11.14.1 ClouDr Group Company Information

    • 11.14.2 ClouDr Group Digital Chronic Disease Management Product Offered

    • 11.14.3 ClouDr Group Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 ClouDr Group Main Business Overview

    • 11.14.5 ClouDr Group Latest Developments

  • 11.15 JD Health

    • 11.15.1 JD Health Company Information

    • 11.15.2 JD Health Digital Chronic Disease Management Product Offered

    • 11.15.3 JD Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 JD Health Main Business Overview

    • 11.15.5 JD Health Latest Developments

  • 11.16 Ali Health

    • 11.16.1 Ali Health Company Information

    • 11.16.2 Ali Health Digital Chronic Disease Management Product Offered

    • 11.16.3 Ali Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.16.4 Ali Health Main Business Overview

    • 11.16.5 Ali Health Latest Developments

  • 11.17 Ping An Good Doctor

    • 11.17.1 Ping An Good Doctor Company Information

    • 11.17.2 Ping An Good Doctor Digital Chronic Disease Management Product Offered

    • 11.17.3 Ping An Good Doctor Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.17.4 Ping An Good Doctor Main Business Overview

    • 11.17.5 Ping An Good Doctor Latest Developments

  • 11.18 We Doctor Group

    • 11.18.1 We Doctor Group Company Information

    • 11.18.2 We Doctor Group Digital Chronic Disease Management Product Offered

    • 11.18.3 We Doctor Group Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.18.4 We Doctor Group Main Business Overview

    • 11.18.5 We Doctor Group Latest Developments

  • 11.19 Medlinker

    • 11.19.1 Medlinker Company Information

    • 11.19.2 Medlinker Digital Chronic Disease Management Product Offered

    • 11.19.3 Medlinker Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2021-2026)

    • 11.19.4 Medlinker Main Business Overview

    • 11.19.5 Medlinker Latest Developments

• 12 Research Findings and Conclusion